These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30091238)

  • 1. Association of survival and hyperthermia after rt-PA for ischemic stroke.
    Ueno T; Nishijima H; Hikichi H; Haga R; Arai A; Suzuki C; Nunomura JI; Tomiyama M
    Acta Neurol Scand; 2018 Dec; 138(6):574-578. PubMed ID: 30091238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.
    Mione G; Ducrocq X; Thilly N; Lacour JC; Vespignani H; Richard S
    Geriatr Gerontol Int; 2016 Jul; 16(7):843-9. PubMed ID: 26245693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis.
    Gadalean F; Simu M; Parv F; Vorovenci R; Tudor R; Schiller A; Timar R; Petrica L; Velciov S; Gluhovschi C; Bob F; Mihaescu A; Timar B; Spasovski G; Ivan V
    PLoS One; 2017; 12(10):e0185589. PubMed ID: 29040276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild stroke: safety and outcome in patients receiving thrombolysis.
    Logallo N; Kvistad CE; Naess H; Waje-Andreassen U; Thomassen L
    Acta Neurol Scand Suppl; 2014; (198):37-40. PubMed ID: 24588505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.
    Gilliot S; Sibon I; Mas JL; Moulin T; Béjot Y; Cordonnier C; Giroud M; Odou P; Bordet R; Vivien D; Leys D;
    J Neurol; 2018 May; 265(5):1166-1173. PubMed ID: 29549467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
    Awadh M; MacDougall N; Santosh C; Teasdale E; Baird T; Muir KW
    Stroke; 2010 Sep; 41(9):1990-5. PubMed ID: 20705933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.
    Takenaka K; Kato M; Yamauti K; Hayashi K
    J Stroke Cerebrovasc Dis; 2014; 23(10):2748-2752. PubMed ID: 25307430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
    Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM
    Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hyperthermia on prognosis after acute ischemic stroke.
    Saini M; Saqqur M; Kamruzzaman A; Lees KR; Shuaib A;
    Stroke; 2009 Sep; 40(9):3051-9. PubMed ID: 19644066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.
    Leys D; Hommet Y; Jacquet C; Moulin S; Sibon I; Mas JL; Moulin T; Giroud M; Sagnier S; Cordonnier C; Medeiros de Bustos E; Turc G; Ronzière T; Bejot Y; Detante O; Ouk T; Mendyk AM; Favrole P; Zuber M; Triquenot-Bagan A; Ozkul-Wermester O; Montoro FM; Lamy C; Faivre A; Lebouvier L; Potey C; Poli M; Hénon H; Renou P; Dequatre-Ponchelle N; Bodenant M; Debruxelles S; Rossi C; Bordet R; Vivien D;
    Neurology; 2016 Dec; 87(23):2416-2426. PubMed ID: 27815401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.